Article citationsMore>>

Mottet, N., van den Bergh, R.C., Briers, E., Van den Broeck, T., Cumberbatch, M.G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen, S., Grivas, N., Grummet, J., Henry, A.M., van der Kwast, T.H., Lam, T.B., Lardas, M., Liew, M., Mason, M.D., Moris, L. and Cornford P. (2021) EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer 2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. European Urology, 79, 243-262.
https://doi.org/10.1016/j.eururo.2020.09.042

has been cited by the following article:

• TITLE: Aminated Cyclopropylmethylphosphonates as Potent Prostate Cancer Inhibitors

  AUTHORS: Abed Al Aziz Al Quntar, Ibrahim Abasy

  KEYWORDS: Prostate Cancer, Cancer, Cyclopropylphophonates, Aminophosphonates, Cyclopropanes, Phosphonates, Alkynylphosphonates, Anti-Cancer, Prostate

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.12 No.7, July 23, 2024

  ABSTRACT: Inspired by the anti-pancreatic promising results of our novel aminated cyclopropylmethylphosphonate compounds, an in vitro anti-prostate cancer activity exploration of these compounds was carried out on human prostate cancer cell line PC-3, and showed potent inhibiting activity at low micromolar concentrations (with an IC50 of approximately 45 μM).